On Monday, July 30th, FDA released the medical device user fee rates for fiscal year 2019. The total FY 2019 revenue amount, prior to adjustments, is $190,654,875. Medical device user fee rates are updated each fiscal year and must be paid at or before the time of submittal to avoid delays in the review process.
Medical device user fee rates are split up into two categories based on the size of the business submitting the application. The updated rates for FY 2019 are as follows:
Application Type | Standard Fee for FY 2019 | Small Business Fee for FY 2019 |
Premarket Application (PMA, BLA, PDP) | $322,147 | $80,537 |
Premarket Report | $322,147 | $80,537 |
Efficacy Supplement | $322,147 | $80,537 |
Panel-track Supplement | $241,610 | $60,403 |
De Novo Classification Request | $96,644 | $24,161 |
180-Day Supplement | $48,322 | $12,081 |
Real-time Supplement | $22,550 | $5,638 |
510(k) Premarket Notification Submission | $10,953 | $2,738 |
30-Day Notice | $5,154 | $2,577 |
513(g) Request for Classification Information | $4,349 | $2,175 |
Annual Fee for Periodic Reporting (Class III Device) | $11,275 | $2,819 |
Annual Establishment Registration Fee | $4,884 | $4,884 |
August 3, 2016
On Friday, July 29th, FDA announced its 2017 Medical Device User Fee rates and payment procedures, which will take effect on October 1, 2016 and remain in place until September 30, 2017. These fees...
August 4, 2015
Starting in 2002, the FDA began implementing "user fees" in which manufacturers of medical devices wishing to obtain approval from the Agency would pay the pre-specified amount in return for the...
August 8, 2018
On Tuesday, July 31st, FDA released a notice with updated biosimilar user fee rates for fiscal year 2019. The base revenue for FY 2019 is $40,214,000, not adjusted for inflation or operating...